These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16484770)

  • 21. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis.
    Baddini Martinez JA; Martinez TY; Lovetro Galhardo FP; de Castro Pereira CA
    Med Sci Monit; 2002 Jun; 8(6):CR405-10. PubMed ID: 12070430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the 15-steps climbing exercise oximetry test in patients with idiopathic pulmonary fibrosis.
    Rusanov V; Shitrit D; Fox B; Amital A; Peled N; Kramer MR
    Respir Med; 2008 Jul; 102(7):1080-8. PubMed ID: 18457939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.
    Lynch DA; Godwin JD; Safrin S; Starko KM; Hormel P; Brown KK; Raghu G; King TE; Bradford WZ; Schwartz DA; Richard Webb W;
    Am J Respir Crit Care Med; 2005 Aug; 172(4):488-93. PubMed ID: 15894598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results.
    Ambrosini V; Zompatori M; De Luca F; Antonia D; Allegri V; Nanni C; Malvi D; Tonveronachi E; Fasano L; Fabbri M; Fanti S
    J Nucl Med; 2010 Dec; 51(12):1950-5. PubMed ID: 21078794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study.
    Orens JB; Kazerooni EA; Martinez FJ; Curtis JL; Gross BH; Flint A; Lynch JP
    Chest; 1995 Jul; 108(1):109-15. PubMed ID: 7606943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis.
    Vainshelboim B; Oliveira J; Yehoshua L; Weiss I; Fox BD; Fruchter O; Kramer MR
    Respiration; 2014; 88(5):378-88. PubMed ID: 25341682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation.
    Mogulkoc N; Brutsche MH; Bishop PW; Greaves SM; Horrocks AW; Egan JJ;
    Am J Respir Crit Care Med; 2001 Jul; 164(1):103-8. PubMed ID: 11435247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung shrinking assessment on HRCT with elastic registration technique for monitoring idiopathic pulmonary fibrosis.
    Sun H; Yang X; Sun X; Meng X; Kang H; Zhang R; Zhang H; Liu M; Dai H; Wang C
    Eur Radiol; 2023 Apr; 33(4):2279-2288. PubMed ID: 36424500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis.
    Nolan CM; Maddocks M; Maher TM; Canavan JL; Jones SE; Barker RE; Patel S; Jacob J; Cullinan P; Man WD
    Respirology; 2018 May; 23(5):498-506. PubMed ID: 29139195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic obstructive pulmonary disorder (COPD) patients with the syndrome of combined pulmonary fibrosis and emphysema, compared to patients with emphysema alone].
    Weiner P; Novitzky T; Weiner D; Beckerman M
    Harefuah; 2013 May; 152(5):294-8, 308, 307. PubMed ID: 23885455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification.
    Palermo M; Tiralongo F; Distefano G; Vancheri A; Giuffrè M; Pino F; Foti PV; Sambataro G; Vancheri C; Palmucci S; Basile A
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33445645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.
    Peckham RM; Shorr AF; Helman DL
    Respiration; 2004; 71(2):165-9. PubMed ID: 15031572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exertional acidotic responses in idiopathic pulmonary fibrosis: the mechanisms of exertional dyspnea.
    Miki K; Maekura R; Miki M; Kitada S; Yoshimura K; Tateishi Y; Mori M
    Respir Physiol Neurobiol; 2013 Feb; 185(3):653-8. PubMed ID: 23246672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment.
    Best AC; Lynch AM; Bozic CM; Miller D; Grunwald GK; Lynch DA
    Radiology; 2003 Aug; 228(2):407-14. PubMed ID: 12802000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic pulmonary fibrosis: predicting response to therapy and survival.
    Gay SE; Kazerooni EA; Toews GB; Lynch JP; Gross BH; Cascade PN; Spizarny DL; Flint A; Schork MA; Whyte RI; Popovich J; Hyzy R; Martinez FJ
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1063-72. PubMed ID: 9563720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.
    Swigris JJ; Streiner DL; Brown KK; Belkin A; Green KE; Wamboldt FS;
    Respir Med; 2014 Jan; 108(1):181-8. PubMed ID: 24388667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The correlation of helper T lymphocyte 1/helper T lymphocyte 2 with clinical and image features in patients with idiopathic pulmonary fibrosis].
    Peng SC; Hu X; Wei LQ; Li ZH
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):489-93. PubMed ID: 24059996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis.
    Daniil ZD; Papageorgiou E; Koutsokera A; Kostikas K; Kiropoulos T; Papaioannou AI; Gourgoulianis KI
    Pulm Pharmacol Ther; 2008; 21(1):26-31. PubMed ID: 17161968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
    Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
    BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis.
    Tajiri M; Okamoto M; Fujimoto K; Johkoh T; Ono J; Tominaga M; Azuma K; Kawayama T; Ohta S; Izuhara K; Hoshino T
    Respir Investig; 2015 Mar; 53(2):73-81. PubMed ID: 25745852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.